Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease

Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease

Stevens–Johnson syndrome (SJS) is a severe mucocutaneous adverse drug reaction with a relatively high mortality rate. SJS is described during herpes simplex virus type 1 (HSV1) infection and, rarely, even during adalimumab therapy. We report the case of a patient with Crohn’s disease who developed S...

Full description

Bibliographic Details
Main Authors: Jenny Roselli, Tommaso Innocenti, Erica Nicola Lynch, Laura Parisio, Pasquale Apolito, Tommaso Mello, Giuseppe Macrì, Monica Milla, Maria Rosa Biagini, Mirko Tarocchi, Stefano Milani, Andrea Galli
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Gastrointestinal Medicine
Online Access:http://dx.doi.org/10.1155/2020/3875024

Internet

http://dx.doi.org/10.1155/2020/3875024

Similar Items